The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy

Abstract Alzheimer disease (AD) is characterized by the deposition of amyloid fibrils, such as senile plaques, composed of amyloid β peptide (Aβ). As a novel therapeutic modality, we have previously developed an azobenzene–boron complex type photocatalyst that photo-oxygenates Aβ fibrils. And the in...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuichi Kawai, Mai Kuriyama, Youhei Sohma, Motomu Kanai, Yukiko Hori, Taisuke Tomita
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-10880-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332798864752640
author Yuichi Kawai
Mai Kuriyama
Youhei Sohma
Motomu Kanai
Yukiko Hori
Taisuke Tomita
author_facet Yuichi Kawai
Mai Kuriyama
Youhei Sohma
Motomu Kanai
Yukiko Hori
Taisuke Tomita
author_sort Yuichi Kawai
collection DOAJ
description Abstract Alzheimer disease (AD) is characterized by the deposition of amyloid fibrils, such as senile plaques, composed of amyloid β peptide (Aβ). As a novel therapeutic modality, we have previously developed an azobenzene–boron complex type photocatalyst that photo-oxygenates Aβ fibrils. And the in vivo photo-oxygenation reaction using this photocatalyst successfully reduced the Aβ fibrils in the brain. Since Aβ fibril is one of the causative molecules in the brains of AD patients, the photocatalyst is expected to be a new modality for disease-modifying therapy against AD. However, the exact relationship between light energy and photo-oxygenating activity for Aβ fibrils remains unclear. In this paper, we have demonstrated using mass spectrometric analysis that the number of oxygens added to Aβ fibrils was increased in a sigmoidal curve with the logarithm of light energy. We also showed that it depended on the total light energy, not on the irradiance. These data suggest that photo-oxygenation proceeds at even lower levels of light energy, and it may be possible to induce photo-oxygenation in areas where light penetration is difficult, such as the human brain.
format Article
id doaj-art-a4e98cf78eb94cb09b04adb4561b9f1c
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-a4e98cf78eb94cb09b04adb4561b9f1c2025-08-20T03:46:07ZengNature PortfolioScientific Reports2045-23222025-07-011511810.1038/s41598-025-10880-8The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energyYuichi Kawai0Mai Kuriyama1Youhei Sohma2Motomu Kanai3Yukiko Hori4Taisuke Tomita5Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of TokyoLaboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of TokyoDepartment of Medicinal Chemistry, School of Pharmaceutical Sciences, Wakayama Medical UniversityLaboratory of Synthetic Organic Chemistry, Graduate School of Pharmaceutical Sciences, The University of TokyoLaboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of TokyoLaboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of TokyoAbstract Alzheimer disease (AD) is characterized by the deposition of amyloid fibrils, such as senile plaques, composed of amyloid β peptide (Aβ). As a novel therapeutic modality, we have previously developed an azobenzene–boron complex type photocatalyst that photo-oxygenates Aβ fibrils. And the in vivo photo-oxygenation reaction using this photocatalyst successfully reduced the Aβ fibrils in the brain. Since Aβ fibril is one of the causative molecules in the brains of AD patients, the photocatalyst is expected to be a new modality for disease-modifying therapy against AD. However, the exact relationship between light energy and photo-oxygenating activity for Aβ fibrils remains unclear. In this paper, we have demonstrated using mass spectrometric analysis that the number of oxygens added to Aβ fibrils was increased in a sigmoidal curve with the logarithm of light energy. We also showed that it depended on the total light energy, not on the irradiance. These data suggest that photo-oxygenation proceeds at even lower levels of light energy, and it may be possible to induce photo-oxygenation in areas where light penetration is difficult, such as the human brain.https://doi.org/10.1038/s41598-025-10880-8Alzheimer diseaseAmyloid βClearancePhoto-oxygenationPhotocatalyst
spellingShingle Yuichi Kawai
Mai Kuriyama
Youhei Sohma
Motomu Kanai
Yukiko Hori
Taisuke Tomita
The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy
Scientific Reports
Alzheimer disease
Amyloid β
Clearance
Photo-oxygenation
Photocatalyst
title The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy
title_full The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy
title_fullStr The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy
title_full_unstemmed The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy
title_short The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy
title_sort dynamics of oxygenation to aβ fibrils using an azobenzene boron complex type photocatalyst and light energy
topic Alzheimer disease
Amyloid β
Clearance
Photo-oxygenation
Photocatalyst
url https://doi.org/10.1038/s41598-025-10880-8
work_keys_str_mv AT yuichikawai thedynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT maikuriyama thedynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT youheisohma thedynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT motomukanai thedynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT yukikohori thedynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT taisuketomita thedynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT yuichikawai dynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT maikuriyama dynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT youheisohma dynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT motomukanai dynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT yukikohori dynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy
AT taisuketomita dynamicsofoxygenationtoabfibrilsusinganazobenzeneboroncomplextypephotocatalystandlightenergy